Loading organizations...
§ Private Profile · Emeryville, CA, USA
Developer of matrix regulator therapeutics for various diseases.
Symic Biomedical has raised $82.5M across 5 funding rounds.
Symic Biomedical has raised $82.5M in total across 5 funding rounds.
Symic Biomedical has raised $82.5M in total across 5 funding rounds.
Symic Biomedical's investors include Cell Innovation Partners, HEDA Ventures, Armen Shanafelt, National Institutes of Health, Ally Bridge Group, Claus Christiansen, InCube Ventures, Mission Bay Capital, Mitsui & Co. Global Investment, Purdue Research Foundation, QB3 Partners.
Symic Biomedical has raised $82.5M across 5 funding rounds. Most recently, it raised $11.0M Other Equity in April 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 26, 2019 | $11M Venture Round | Cell Innovation Partners | — | Announced |
| May 22, 2017 | $30M Series B | — | Heda Ventures | Announced |
| Dec 1, 2015 | $25M Series A | Armen Shanafelt | — | Announced |
| Aug 27, 2015 | $1.5M Grant | National Institutes OF Health | — | Announced |
| Jan 5, 2015 | $15M Series A | Armen Shanafelt | Ally Bridge Group, Claus Christiansen, InCube Ventures, Mission BAY Capital, Mitsui & CO. Global Investment, Purdue Research Foundation, QB3 Partners | Announced |